Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced Melanoma

Robert, C; Carlino, MS; Mcneil, C; Ribas, A; Grob, JJ; Schachter, J; Nyakas, M; Kee, D; Petrella, TM; Blaustein, A; Lotem, M; Arance, A; Daud, AI; Hamid, O; Larkin, J; Anderson, J; Krepler, C; Grebennik, D; Long, GV

Robert, C (通讯作者),Gustave Roussy, 39 rue Camille Desmoulins, F-94805 Villejuif, France.

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (24): 3998

Abstract

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, m......

Full Text Link